Fox Chase Cancer Center News

PHILADELPHIA (November 15, 2021)— Gary Barbera and his Barbera Cares Ambassadors of Gary Barbera’s on the Boulevard, in partnership with State Representative Jared G. Solomon, will present a check for $10,000 to Fox Chase Cancer Center on November 22, money that will help improve the lives of patients and families affected by breast cancer.

PHILADELPHIA (November 9, 2021)—Cihangir Duy, PhD, MS, an assistant professor in the Cancer Signaling and Epigenetics Program at Fox Chase Cancer Center, has been awarded a one-year $100,000 Hollis Brownstein Research Grant from The Leukemia Research Foundation. The grant will fund research into how certain acute myeloid leukemia (AML) cells can reactivate following chemotherapy, thus causing disease relapse.

PHILADELPHIA (November 8, 2021)—Fox Chase Cancer Center has been recognized for excellence in patient care with two Press Ganey Awards, the Pinnacle of Excellence Award and the Guardian of Excellence Award.

PHILADELPHIA (November 8, 2021)—In Vino Vita, Fox Chase Cancer Center’s signature fundraising event, was held on October 30 at the National Constitution Center, and raised over $1.5 million for cancer research, treatment and prevention.

PHILADELPHIA (November 4, 2021)—As more radiographic, histopathologic, and genomic data are gathered and made accessible, it is only a matter of time until artificial intelligence (AI) becomes part of the regular clinical workflow for treating kidney cancer, according to a review article published by researchers at Fox Chase Cancer Center.

PHILADELPHIA (November 3, 2021)—Benjamin A. Young, CCRP, has been appointed Program Manager at the Marvin & Concetta Greenberg Pancreatic Cancer Institute, where he will work with researchers to coordinate the institute’s basic, clinical, and population sciences research programs.

PHILADELPHIA (November 2, 2021)—Marcin Chwistek, MD, FAAHPM, director of the Supportive Oncology and Palliative Care Program at Fox Chase Cancer Center, will be speaking virtually at the Hospice Care Professionals Association Conference being held in Moscow November 2-3.

PHILADELPHIA (October 25, 2021)—A multi-institutional retrospective analysis conducted by researchers at Fox Chase Cancer Center has found that early stage prostate cancer patients treated with moderately hypofractionated intensity-modulated radiation therapy or proton beam radiation therapy had low risk of serious late genitourinary and gastrointestinal complications.